Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma

Metallothionein-3 has poorly characterized functions in neuroblastoma. Cisplatin-based chemotherapy is a major regimen to treat neuroblastoma, but its clinical efficacy is limited by chemoresistance. We investigated the impact of human metallothionein-3 (hMT3) up-regulation in neuroblastoma cells an...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Rodrigo, Miguel Angel Merlos, Michalkova, Hana, Strmiska, Vladislav, Casar, Berta, Crespo, Piero, de los Rios, Vivian, Ignacio Casal, J., Haddad, Yazan, Guran, Roman, Eckschlager, Tomas, Pokorna, Petra, Heger, Zbynek, Adam, Vojtech
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7943580/
https://ncbi.nlm.nih.gov/pubmed/33750814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-84185-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia